An experimental gene therapy infused directly into the human brain has been found to reduce monthly seizures by more than 90 per cent in people with drug-resistant epilepsy.
The groundbreaking clinical trial, published in The New England Journal of Medicine, marks a significant advance in treating neurological disorders that fail to respond to standard pharmaceuticals.